Pekin Hardy Strauss’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Pekin Hardy Strauss’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-30,551	Closed	-$3.12M	–	177
2014 Q4	$3.12M	Buy	+30,551	New	+$2.98M	0.46%	47

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pekin Hardy Strauss's FBT Position: Q1 2015 in Review

Pekin Hardy Strauss sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2015, closing a stake of 30,551 shares — an estimated $3.12M sold.

Pekin Hardy Strauss first reported a position in FBT in Q4 2014 and held it in 1 quarter. The position peaked at $3.12M in Q4 2014. 122 funds tracked by Wall St. Rank hold FBT as of Q1 2015.

Pekin Hardy Strauss reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2015 after selling out during the quarter.
Pekin Hardy Strauss sold 30,551 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2015, an estimated $3.12M.
Pekin Hardy Strauss first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 1 quarter.
Pekin Hardy Strauss's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.12M in Q4 2014.
122 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2015.

Based on Pekin Hardy Strauss's 13F filing for Q1 2015, filed 11 May 2015.